Cargando…

Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform

OBJECTIVES: With a rapidly growing list of candidate immune‐based cancer therapeutics, there is a critical need to generate highly reliable animal models to preclinically evaluate the efficacy of emerging immune‐based therapies, facilitating successful clinical translation. Our aim was to design and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shenoy, Gautam N, Greene, Christopher J, Bhatta, Maulasri, Baroja, Miren L, Loyall, Jenni L, Balu‐Iyer, Sathy V, Kelleher, Raymond J, Carreno, Beatriz M, Linette, Gerald P, Shultz, Leonard D, Bankert, Richard B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853904/ https://www.ncbi.nlm.nih.gov/pubmed/33552509 http://dx.doi.org/10.1002/cti2.1246

Ejemplares similares

Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments
por: Bhatta, Maulasri, et al.
Publicado: (2021)

Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments
por: Shenoy, Gautam N., et al.
Publicado: (2021)

Humanized Mouse Model of Ovarian Cancer Recapitulates Patient Solid Tumor Progression, Ascites Formation, and Metastasis
por: Bankert, Richard B., et al.
Publicado: (2011)

Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins
por: Nguyen, Nhan H., et al.
Publicado: (2021)

Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development
por: Sauna, Zuben E., et al.
Publicado: (2023)

Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins
por: Jarvi, Nicole L., et al.
Publicado: (2021)

4473 Immune control of plasma cell disorders – in-depth analysis of Sox2 immunity in MGUS
por: Susanibar Adaniya, Sandra Patricia, et al.
Publicado: (2020)

Dendritic cell-based vaccines: Shining the spotlight on signal 3
por: Linette, Gerald P, et al.
Publicado: (2013)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

p58(IPK) suppresses NLRP3 inflammasome activation and IL-1β production via inhibition of PKR in macrophages
por: Boriushkin, Evgenii, et al.
Publicado: (2016)

Reduction of Endoplasmic Reticulum Stress Improves Angiogenic Progenitor Cell function in a Mouse Model of Type 1 Diabetes
por: Bhatta, Maulasri, et al.
Publicado: (2018)

Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
por: Kerstetter-Fogle, Amber E., et al.
Publicado: (2020)

Preclinical therapeutics ex ovo quail eggs as a biomimetic automation-ready xenograft platform
por: Rasmussen, Samuel V., et al.
Publicado: (2021)

Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
por: Yin, Jie, et al.
Publicado: (2023)

Preclinical transgenic and patient‐derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma
por: Boult, Jessica K. R., et al.
Publicado: (2017)

Surface Cytotoxic T Lymphocyte–associated Antigen 4 Partitions Within Lipid Rafts and Relocates to the Immunological Synapse under Conditions of Inhibition of T Cell Activation
por: Darlington, Peter J., et al.
Publicado: (2002)

Curcumin-Artemisinin Coamorphous Solid: Xenograft Model Preclinical Study
por: Mannava, M. K. Chaitanya, et al.
Publicado: (2018)

PATIENT-DERIVED XENOGRAFTS AS A PRECLINICAL MODEL FOR BONE SARCOMAS
por: MEOHAS, WALTER, et al.
Publicado: (2018)

A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies
por: Hooper, Jody E., et al.
Publicado: (2015)

Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
por: Jung, Joohee
Publicado: (2014)

Patient-derived xenografts: a relevant preclinical model for drug development
por: Pompili, Luca, et al.
Publicado: (2016)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Patient-derived xenografts: a promising resource for preclinical cancer research
por: Karamboulas, Christina, et al.
Publicado: (2019)

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
por: William, Doreen, et al.
Publicado: (2017)

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
por: Jäger, Wolfgang, et al.
Publicado: (2015)

Circadian rhythm impacts preclinical FDG-PET quantification in the brain, but not in xenograft tumors
por: Krueger, Marcel A., et al.
Publicado: (2020)

A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells in Vivo
por: Pascoal, Susana, et al.
Publicado: (2020)

Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma
por: Tatari, Nazanin, et al.
Publicado: (2020)

Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
por: Kleinmanns, Katrin, et al.
Publicado: (2022)

Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
por: Serra-Camprubí, Queralt, et al.
Publicado: (2023)

Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials
por: Chateau-Joubert, Sophie, et al.
Publicado: (2021)

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
por: Nanni, Patrizia, et al.
Publicado: (2019)

Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models
por: Owonikoko, Taofeek K., et al.
Publicado: (2019)

An avian embryo patient-derived xenograft model for preclinical studies of human breast cancers
por: Jarrosson, Loraine, et al.
Publicado: (2021)

Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool
por: Villafranca-Magdalena, Beatriz, et al.
Publicado: (2022)

Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
por: Bear, Adham S., et al.
Publicado: (2021)

Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models
por: Suri, Kanika, et al.
Publicado: (2021)

Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
por: Kamili, Alvin, et al.
Publicado: (2020)

Establishment of various biliary tract carcinoma cell lines and xenograft models for appropriate preclinical studies
por: Ojima, Hidenori, et al.
Publicado: (2016)

Bladder Reconstruction with Human Amniotic Membrane in a Xenograft Rat Model: A Preclinical Study
por: Barski, Dimitri, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d3hsle1l7hnu6764mqe4fbj49n